randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als A Multicenter, Randomized, Double-blind, Clinical Efficacy in Patients with Dementia Associated with Cerebrovascular Disease Efficacy and safety of low-dose
Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet A 1 year multicenter placebo controlled study of acetyl L carnitine in patients with Alzheimer's disease Neurology The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
00262-4/asset/89dd934c-f271-4a89-9f55-b9a4707e82c0/main.assets/gr3_lrg.jpg)


